BR0312424A8 - derivados de pirazoloisoquinolinas para inibição de quinase indutora de nfkappab - Google Patents
derivados de pirazoloisoquinolinas para inibição de quinase indutora de nfkappabInfo
- Publication number
- BR0312424A8 BR0312424A8 BRPI0312424A BR0312424A BR0312424A8 BR 0312424 A8 BR0312424 A8 BR 0312424A8 BR PI0312424 A BRPI0312424 A BR PI0312424A BR 0312424 A BR0312424 A BR 0312424A BR 0312424 A8 BR0312424 A8 BR 0312424A8
- Authority
- BR
- Brazil
- Prior art keywords
- pyrazoloisoquinolines
- nfkappab
- derivatives
- kinase inhibition
- inducing kinase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
"derivados de pirazoloisoquinolinas para inibição de quinase indutora de nfkappab". compostos da fórmula (i) são apropriados para a preparação de medicamentos para profilaxia e terapia de doenças, cujo desenvolvimento está relacionado com uma atividade reforçada de nik.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10229762A DE10229762A1 (de) | 2002-07-03 | 2002-07-03 | Pyrazoloisoquinolinenderivaten zur Inhibierung von NFkappaB-induzierende Kinase |
PCT/EP2003/006500 WO2004005287A1 (de) | 2002-07-03 | 2003-06-20 | Pyrazoloisoquinolinenderivaten zur inhibierung von nfkappab-induzierende kinase |
Publications (3)
Publication Number | Publication Date |
---|---|
BR0312424A BR0312424A (pt) | 2005-04-26 |
BR0312424A8 true BR0312424A8 (pt) | 2016-02-16 |
BRPI0312424A8 BRPI0312424A8 (pt) | 2016-02-16 |
Family
ID=29761582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0312424A BRPI0312424A8 (pt) | 2002-07-03 | 2003-06-20 | Derivados de pirazoloisoquinolinas para inibição de quinase indutora de nfkappab |
Country Status (12)
Country | Link |
---|---|
US (1) | US6841556B2 (pt) |
EP (1) | EP1519934B1 (pt) |
JP (1) | JP4603355B2 (pt) |
AT (1) | ATE373658T1 (pt) |
AU (1) | AU2003242737B2 (pt) |
BR (1) | BRPI0312424A8 (pt) |
CA (1) | CA2490571C (pt) |
DE (2) | DE10229762A1 (pt) |
IL (1) | IL165995A0 (pt) |
MX (1) | MXPA05000038A (pt) |
TW (1) | TW200418852A (pt) |
WO (1) | WO2004005287A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7132428B2 (en) * | 2003-07-03 | 2006-11-07 | Aventis Pharmaceuticals Inc. | Pyrazoloisoquinoline derivative as kinase inhibitors for the treatment of various disorders |
WO2006040645A1 (en) * | 2004-10-11 | 2006-04-20 | Ranbaxy Laboratories Limited | N-(3,5-dichloropyridin-4-yl)-2,4,5-alkoxy and 2,3,4-alkoxy benzamide derivatives as pde-iv (phophodiesterase type-iv) inhibitors for the treatment of inflammatory diseases such as asthma |
WO2009158011A1 (en) * | 2008-06-26 | 2009-12-30 | Amgen Inc. | Alkynyl alcohols as kinase inhibitors |
FR2944792B1 (fr) | 2009-04-24 | 2011-05-20 | Sanofi Aventis | Derives de 1h-pyrazolo[4,3-c]isoquinoleines, leur preparation et leur application en therapeutique |
EP2551670A1 (en) | 2011-07-27 | 2013-01-30 | Merck Patent GmbH | NIK inhibitors cell-based assay |
EP4169904A1 (en) | 2021-10-25 | 2023-04-26 | Yukin Therapeutics | Substituted quinolines as improved nf-kb-inducing kinase (nik) inhibitors |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8419658D0 (en) * | 1984-08-01 | 1984-09-05 | Wellcome Found | Nitrogen containing heterocyclic compounds |
GB8600752D0 (en) * | 1986-01-14 | 1986-02-19 | Roussel Lab Ltd | Chemical compounds |
US4748246A (en) * | 1987-05-07 | 1988-05-31 | American Home Products Corporation | Pyrazolo(4,3-c)quinolines |
US5124337A (en) * | 1991-05-20 | 1992-06-23 | Schering Corporation | N-acyl-tetrahydroisoquinolines as inhibitors of acyl-coenzyme a:cholesterol acyl transferase |
ES2111059T3 (es) * | 1991-07-30 | 1998-03-01 | Ciba Geigy Ag | Derivados de hidroxilamina substituidos con heteroarilo como inhibidores de lipoxigenasa. |
GB9322828D0 (en) * | 1993-11-05 | 1993-12-22 | Sandoz Ltd | Organic compounds |
ID16283A (id) * | 1996-03-20 | 1997-09-18 | Astra Pharma Prod | Senyawa yang berguna dibidang farmasi |
WO1999002528A1 (en) * | 1997-07-09 | 1999-01-21 | Astra Pharmaceuticals Ltd. | Novel compounds |
EP1134221A1 (en) * | 2000-03-15 | 2001-09-19 | Aventis Pharma Deutschland GmbH | Substituted beta-carbolines as lkB kinase inhibitors |
JP2002193938A (ja) * | 2000-12-01 | 2002-07-10 | Bayer Ag | 4−アリールピリジン誘導体 |
CA2460939C (en) | 2001-09-19 | 2008-07-29 | Pharmacia Corporation | Substituted pyrazolyl compounds for the treatment of inflammation |
-
2002
- 2002-07-03 DE DE10229762A patent/DE10229762A1/de not_active Withdrawn
-
2003
- 2003-06-20 JP JP2004518545A patent/JP4603355B2/ja not_active Expired - Fee Related
- 2003-06-20 DE DE50308230T patent/DE50308230D1/de not_active Expired - Lifetime
- 2003-06-20 BR BRPI0312424A patent/BRPI0312424A8/pt not_active Application Discontinuation
- 2003-06-20 MX MXPA05000038A patent/MXPA05000038A/es active IP Right Grant
- 2003-06-20 AT AT03762498T patent/ATE373658T1/de not_active IP Right Cessation
- 2003-06-20 WO PCT/EP2003/006500 patent/WO2004005287A1/de active IP Right Grant
- 2003-06-20 CA CA2490571A patent/CA2490571C/en not_active Expired - Fee Related
- 2003-06-20 AU AU2003242737A patent/AU2003242737B2/en not_active Ceased
- 2003-06-20 EP EP03762498A patent/EP1519934B1/de not_active Expired - Lifetime
- 2003-07-01 TW TW092117902A patent/TW200418852A/zh unknown
- 2003-07-03 US US10/613,482 patent/US6841556B2/en not_active Expired - Lifetime
-
2004
- 2004-12-26 IL IL16599504A patent/IL165995A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2490571C (en) | 2011-03-15 |
TW200418852A (en) | 2004-10-01 |
CA2490571A1 (en) | 2004-01-15 |
BR0312424A (pt) | 2005-04-26 |
US6841556B2 (en) | 2005-01-11 |
EP1519934A1 (de) | 2005-04-06 |
AU2003242737B2 (en) | 2009-01-22 |
MXPA05000038A (es) | 2005-04-08 |
IL165995A0 (en) | 2006-01-15 |
EP1519934B1 (de) | 2007-09-19 |
WO2004005287A1 (de) | 2004-01-15 |
WO2004005287A9 (de) | 2004-03-04 |
US20040097541A1 (en) | 2004-05-20 |
BRPI0312424A8 (pt) | 2016-02-16 |
DE10229762A1 (de) | 2004-01-22 |
AU2003242737A1 (en) | 2004-01-23 |
JP4603355B2 (ja) | 2010-12-22 |
JP2006513137A (ja) | 2006-04-20 |
DE50308230D1 (de) | 2007-10-31 |
ATE373658T1 (de) | 2007-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL172942A0 (en) | Pyrazoloisoquinoline derivatives as kinase inhibitors | |
DK1194425T3 (da) | Substituerede benzimidazoler | |
ECSP055899A (es) | Pirimidinas inhibidoras de chk, pdk y akt, su producción y su uso como agentes farmacéuticos | |
MY140074A (en) | INDOLE DERIVATIVES OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING IkB KINASE | |
UY27714A1 (es) | 2 - heteroaril - pirimidinas inhibidoras de cdk, su preparación y su uso como medicamentos. | |
ATE408601T1 (de) | Fredericamycin-derivate | |
HRP20020748A2 (en) | Substituted beta-carbolines with ikb-kinase inhibiting activity | |
SV2004001459A (es) | 2- (piridin-2-ilamino) -pirido [2,3-d]pirimidin-7-onas ref. pc20501 | |
NO20054880L (no) | Azaspiroalkanderivater som inhibitorer av metallproeaser | |
YU21702A (sh) | Supstituisani indoli za moduliranje nfkb aktivnosti | |
UY27234A1 (es) | Inhibidores novedosos de tirosina cinasa | |
PT1325011E (pt) | Metodos e compostos para tratamento de doencas proliferativas | |
WO2002060375A3 (en) | Diphenyl ether derivatives and their uses as heparanase inhibitors | |
BRPI0415390A (pt) | compostos de pirazinona substituìda para o tratamento da inflamação | |
BR0312424A8 (pt) | derivados de pirazoloisoquinolinas para inibição de quinase indutora de nfkappab | |
RS20050421A (en) | Aminoindazole derivatives and use thereof as kinase inhibitors | |
PA8579401A1 (es) | Derivados de 2,3-dihidro-isoindol-1-ona como inhibidores de mao-b | |
DK1553938T3 (da) | Anvendelse af epothilonderivater til behandling af hyperparathyroidisme | |
DE50016023D1 (de) | Neue stromelysin inhibitoren | |
CR7866A (es) | Pirimidinas inhibidoras de chk, pdk y akt, su produccion y su uso como agentes farmaceuticos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25D | Requested change of name of applicant approved |
Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) Free format text: ALTERADO DE: AVENTIS PHARMA DEUTSCHLAND GMBH |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: PARA: INT. CL. C07D 471/04; A61K 31/47, 29/00 Ipc: C07D 471/04 (2011.01), A61K 31/47 (2011.01), A61P |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |